- This event has passed.
EBMT
Mar 14 • 1:01 AM
Martine Deprez: Leading with Mathematics, Listening, and Social Responsibility
FDA Approves Teclistamab Plus Daratumumab for Myeloma After ≥1 Prior Line — MajesTEC-3 Data Redefines the Standard of Care
Yvonne Awards 2026
Douglas Flora Shares Key Takeaways from NCODA’s Global Oncology Congress
ARCAGEN Trial at ESMO Sarcoma and Rare Cancers Congress 2026: Genomic Alterations and Access to Precision Therapies
Dean Crowe: Rally Kids - Then and Now
Proud to Announce Our Partnership With GenomOncology and Belay Diagnostics - WeTrials
Servier Acquires Day One Biopharmaceuticals for $2.5B, Betting on Tovorafenib and the Pediatric Glioma Frontier
